Cancer Stage
Subsidies raised uptake above 90% at every cancer stage. Patients with stage IV metastatic cancer had the highest non-subsidised uptake, while patients without personal cancer history had the lowest. Among non-subsidised patients, genetic…
1 sources - 5 claims
Subsidies raised uptake above 90% at every cancer stage. Patients with stage IV metastatic cancer had the highest non-subsidised uptake, while patients without personal cancer history had the lowest. Among non-subsidised patients, genetic testing uptake varied markedly by cancer stage. Advanced disease increases testing uptake because genetic findings can have immediate clinical utility for targeted therapy eligibility. Disease-related urgency can partially substitute for the motivational effect of financial subsidies.